{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:44:11Z","timestamp":1785804251843,"version":"3.56.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":78,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the National Science Centre Poland","award":["2020\/39\/B\/NZ2\/01004"],"award-info":[{"award-number":["2020\/39\/B\/NZ2\/01004"]}]},{"name":"the National Science Centre Poland","award":["2020\/39\/B\/NZ5\/01970"],"award-info":[{"award-number":["2020\/39\/B\/NZ5\/01970"]}]},{"name":"the National Science Centre Poland","award":["2020\/39\/D\/NZ2\/03106"],"award-info":[{"award-number":["2020\/39\/D\/NZ2\/03106"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"DOI":"10.1186\/s11658-026-00933-9","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T19:24:37Z","timestamp":1779132277000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genomic context of mutations in MIR142 in blood cancers: summary and integrative analysis"],"prefix":"10.1186","volume":"31","author":[{"given":"Wladyslaw","family":"Wegorek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Tire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kuznicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Giefing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Klapper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Kozlowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Galka-Marciniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"933_CR1","doi-asserted-by":"publisher","unstructured":"Galka-Marciniak P, Urbanek-Trzeciak MO, Kuznicki D, Szostak N, Tire A, Nawrocka-Muszynska PM, et al. Whole-miRNome sequencing (WMS)\u2014a panel for targeted sequencing of all human miRNA genes. 2025:2025.03.09.641621. https:\/\/doi.org\/10.1101\/2025.03.09.641621.","DOI":"10.1101\/2025.03.09.641621"},{"key":"933_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103051","volume":"61","author":"MO Urbanek-Trzeciak","year":"2020","unstructured":"Urbanek-Trzeciak MO, Galka-Marciniak P, Nawrocka PM, Kowal E, Szwec S, Giefing M, et al. Pan-cancer analysis of somatic mutations in miRNA genes. EBioMedicine. 2020;61:103051. https:\/\/doi.org\/10.1016\/j.ebiom.2020.103051.","journal-title":"EBioMedicine"},{"key":"933_CR3","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1093\/nar\/gkae017","volume":"52","author":"M Suszynska","year":"2024","unstructured":"Suszynska M, Machowska M, Fraszczyk E, Michalczyk M, Philips A, Galka-Marciniak P, et al. CMC: cancer miRNA census\u2014a list of cancer-related miRNA genes. Nucleic Acids Res. 2024;52:1628\u201344. https:\/\/doi.org\/10.1093\/nar\/gkae017.","journal-title":"Nucleic Acids Res"},{"key":"933_CR4","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","volume":"47","author":"A Kozomara","year":"2019","unstructured":"Kozomara A, Birgaoanu M, Griffiths-Jones S. miRBase: from microRNA sequences to function. Nucleic Acids Res. 2019;47:D155\u201362. https:\/\/doi.org\/10.1093\/nar\/gky1141.","journal-title":"Nucleic Acids Res"},{"key":"933_CR5","doi-asserted-by":"publisher","first-page":"D116","DOI":"10.1093\/nar\/gkae1094","volume":"53","author":"AW Clarke","year":"2025","unstructured":"Clarke AW, H\u00f8ye E, Hembrom AA, Paynter VM, Vinther J, Wyro\u017cemski \u0141, et al. MirGeneDB 3.0: improved taxonomic sampling, uniform nomenclature of novel conserved microRNA families and updated covariance models. Nucleic Acids Res. 2025;53:D116\u201328. https:\/\/doi.org\/10.1093\/nar\/gkae1094.","journal-title":"Nucleic Acids Res"},{"key":"933_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-15162-1","volume":"12","author":"P Galka-Marciniak","year":"2022","unstructured":"Galka-Marciniak P, Kandu\u0142a Z, Tire A, Wegorek W, Gwozdz-Bak K, Handschuh L, et al. Mutations in the miR-142 gene are not common in myeloproliferative neoplasms. Sci Rep. 2022;12:10924. https:\/\/doi.org\/10.1038\/s41598-022-15162-1.","journal-title":"Sci Rep"},{"key":"933_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/leu.2016.175","volume":"31","author":"A Bouska","year":"2017","unstructured":"Bouska A, Zhang W, Gong Q, Iqbal J, Scuto A, Vose J, et al. Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma. Leukemia. 2017;31:83\u201391. https:\/\/doi.org\/10.1038\/leu.2016.175.","journal-title":"Leukemia"},{"key":"933_CR8","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.143891","author":"K Hezaveh","year":"2016","unstructured":"Hezaveh K, Kloetgen A, Bernhart SH, Mahapatra KD, Lenze D, Richter J, et al. Alterations of miRNAs and miRNA-regulated mRNA expression in GC B cell lymphomas determined by integrative sequencing analysis. Haematologica. 2016. https:\/\/doi.org\/10.3324\/haematol.2016.143891.","journal-title":"Haematologica"},{"key":"933_CR9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature14666","volume":"526","author":"XS Puente","year":"2015","unstructured":"Puente XS, Be\u00e0 S, Vald\u00e9s-Mas R, Villamor N, Guti\u00e9rrez-Abril J, Mart\u00edn-Subero JI, et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature. 2015;526:519\u201324. https:\/\/doi.org\/10.1038\/nature14666.","journal-title":"Nature"},{"key":"933_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/cam4.29","volume":"1","author":"W Kwanhian","year":"2012","unstructured":"Kwanhian W, Lenze D, Alles J, Motsch N, Barth S, D\u00f6ll C, et al. MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma. Cancer Med. 2012;1:141\u201355. https:\/\/doi.org\/10.1002\/cam4.29.","journal-title":"Cancer Med"},{"key":"933_CR11","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.3324\/haematol.2014.120345","volume":"100","author":"F Thol","year":"2015","unstructured":"Thol F, Scherr M, Kirchner A, Shahswar R, Battmer K, Kade S, et al. Clinical and functional implications of microRNA mutations in a cohort of 935 patients with myelodysplastic syndromes and acute myeloid leukemia. Haematologica. 2015;100:e122\u20134. https:\/\/doi.org\/10.3324\/haematol.2014.120345.","journal-title":"Haematologica"},{"key":"933_CR12","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1182\/blood-2014-10-603951","volume":"125","author":"NJ Kramer","year":"2015","unstructured":"Kramer NJ, Wang W-L, Reyes EY, Kumar B, Chen C-C, Ramakrishna C, et al. Altered lymphopoiesis and immunodeficiency in miR-142 null mice. Blood. 2015;125:3720\u201330. https:\/\/doi.org\/10.1182\/blood-2014-10-603951.","journal-title":"Blood"},{"key":"933_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0832-7","volume":"14","author":"F Talebi","year":"2017","unstructured":"Talebi F, Ghorbani S, Chan WF, Boghozian R, Masoumi F, Ghasemi S, et al. MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis. J Neuroinflammation. 2017;14:55. https:\/\/doi.org\/10.1186\/s12974-017-0832-7.","journal-title":"J Neuroinflammation"},{"key":"933_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/embor.2008.224","volume":"10","author":"B Huang","year":"2009","unstructured":"Huang B, Zhao J, Lei Z, Shen S, Li D, Shen G, et al. miR\u2010142\u20103p restricts cAMP production in CD4+CD25\u2212 T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA. EMBO Rep. 2009;10:180\u20135. https:\/\/doi.org\/10.1038\/embor.2008.224.","journal-title":"EMBO Rep"},{"key":"933_CR15","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1002\/art.34505","volume":"64","author":"S Ding","year":"2012","unstructured":"Ding S, Liang Y, Zhao M, Liang G, Long H, Zhao S, et al. Decreased microRNA-142-3p\/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus. Arthritis Rheum. 2012;64:2953\u201363. https:\/\/doi.org\/10.1002\/art.34505.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"933_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001552","volume":"20","author":"W-L Wang","year":"2022","unstructured":"Wang W-L, Ouyang C, Graham NM, Zhang Y, Cassady K, Reyes EY, et al. microRNA-142 guards against autoimmunity by controlling Treg cell homeostasis and function. PLoS Biol. 2022;20(2):e3001552. https:\/\/doi.org\/10.1371\/journal.pbio.3001552.","journal-title":"PLoS Biol"},{"key":"933_CR17","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.2174\/1570159X21666230404103914","volume":"21","author":"F De Vito","year":"2023","unstructured":"De Vito F, Balletta S, Caioli S, Musella A, Guadalupi L, Vanni V, et al. MiR-142-3p is a critical modulator of TNF-mediated neuronal toxicity in multiple sclerosis. Curr Neuropharmacol. 2023;21:2567\u201382. https:\/\/doi.org\/10.2174\/1570159X21666230404103914.","journal-title":"Curr Neuropharmacol"},{"key":"933_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adl1698","volume":"17","author":"G De Rosa","year":"2025","unstructured":"De Rosa G, Russo C, Garavelli S, Di Silvestre D, Spatocco I, Mele G, et al. MicroRNA-142-3p shuttling in extracellular vesicles marks regulatory T cell dysfunction in multiple sclerosis. Sci Transl Med. 2025;17:eadl1698. https:\/\/doi.org\/10.1126\/scitranslmed.adl1698.","journal-title":"Sci Transl Med"},{"key":"933_CR19","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1158\/0008-5472.CAN-17-3592","volume":"78","author":"MC Trissal","year":"2018","unstructured":"Trissal MC, Wong TN, Yao J-C, Ramaswamy R, Kuo I, Baty J, et al. MIR142 loss-of-function mutations derepress ASH1L to increase HOXA gene expression and promote leukemogenesis. Cancer Res. 2018;78:3510\u201321. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-3592.","journal-title":"Cancer Res"},{"key":"933_CR20","doi-asserted-by":"publisher","first-page":"6172","DOI":"10.1182\/blood-2010-12-325647","volume":"117","author":"Y Sun","year":"2011","unstructured":"Sun Y, Varambally S, Maher CA, Cao Q, Chockley P, Toubai T, et al. Targeting of microRNA-142-3p in dendritic cells regulates endotoxin-induced mortality. Blood. 2011;117:6172\u201383. https:\/\/doi.org\/10.1182\/blood-2010-12-325647.","journal-title":"Blood"},{"key":"933_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41167-z","volume":"14","author":"B Zhang","year":"2023","unstructured":"Zhang B, Zhao D, Chen F, Frankhouser D, Wang H, Pathak KV, et al. Acquired miR-142 deficit in leukemic stem cells suffices to drive chronic myeloid leukemia into blast crisis. Nat Commun. 2023;14:5325. https:\/\/doi.org\/10.1038\/s41467-023-41167-z.","journal-title":"Nat Commun"},{"key":"933_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-020-00183-1","volume":"9","author":"T Kl\u00fcmper","year":"2020","unstructured":"Kl\u00fcmper T, Bruckmueller H, Diewock T, Kaehler M, Haenisch S, Pott C, et al. Expression differences of miR-142-5p between treatment-na\u00efve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistance. Exp Hematol Oncol. 2020;9:26. https:\/\/doi.org\/10.1186\/s40164-020-00183-1.","journal-title":"Exp Hematol Oncol"},{"key":"933_CR23","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1007\/s11033-011-1026-5","volume":"39","author":"F Wang","year":"2012","unstructured":"Wang F, Wang X-S, Yang G-H, Zhai P-F, Xiao Z, Xia L-Y, et al. miR-29a and miR-142-3p downregulation and diagnostic implication in human acute myeloid leukemia. Mol Biol Rep. 2012;39:2713\u201322. https:\/\/doi.org\/10.1007\/s11033-011-1026-5.","journal-title":"Mol Biol Rep"},{"key":"933_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.718731","volume":"11","author":"Z Chen","year":"2021","unstructured":"Chen Z, Xie Y, Liu D, Liu P, Li F, Zhang Z, et al. Downregulation of miR-142a contributes to the enhanced anti-apoptotic ability of murine chronic myelogenous leukemia cells. Front Oncol. 2021;11:718731. https:\/\/doi.org\/10.3389\/fonc.2021.718731.","journal-title":"Front Oncol"},{"key":"933_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cells13010084","volume":"13","author":"W Huang","year":"2024","unstructured":"Huang W, Paul D, Calin GA, Bayraktar R. miR-142: A master regulator in hematological malignancies and therapeutic opportunities. Cells. 2024;13:84. https:\/\/doi.org\/10.3390\/cells13010084.","journal-title":"Cells"},{"key":"933_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56383-y","volume":"16","author":"F Chen","year":"2025","unstructured":"Chen F, Zhao D, Xu Y, Zhang Y, Chen M-H, Pathak KV, et al. miR-142 deficit in T cells during blast crisis promotes chronic myeloid leukemia immune escape. Nat Commun. 2025;16:1253. https:\/\/doi.org\/10.1038\/s41467-025-56383-y.","journal-title":"Nat Commun"},{"key":"933_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-025-01755-6","volume":"18","author":"K Harada","year":"2025","unstructured":"Harada K, Zhao D, Park M, Chen F, Xu Y, Zhang Y, et al. MicroRNA-142 improves IL1RAP CAR-T cell activity in acute myeloid leukemia. J Hematol Oncol. 2025;18:99. https:\/\/doi.org\/10.1186\/s13045-025-01755-6.","journal-title":"J Hematol Oncol"},{"key":"933_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76218-8","volume":"10","author":"A Marshall","year":"2020","unstructured":"Marshall A, Kasturiarachchi J, Datta P, Guo Y, Deltcheva E, James C, et al. Mir142 loss unlocks IDH2R140-dependent leukemogenesis through antagonistic regulation of HOX genes. Sci Rep. 2020;10:19390. https:\/\/doi.org\/10.1038\/s41598-020-76218-8.","journal-title":"Sci Rep"},{"key":"933_CR29","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1111\/cas.15794","volume":"114","author":"S Kawano","year":"2023","unstructured":"Kawano S, Araki K, Bai J, Furukawa I, Tateishi K, Yoshinobu K, et al. A gain-of-function mutation in microRNA 142 is sufficient to cause the development of T-cell leukemia in mice. Cancer Sci. 2023;114:2821\u201334. https:\/\/doi.org\/10.1111\/cas.15794.","journal-title":"Cancer Sci"},{"key":"933_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ado2830","volume":"11","author":"R Bayraktar","year":"2025","unstructured":"Bayraktar R, Tang Y, Dragomir MP, Ivan C, Peng X, Fabris L, et al. The mutational landscape and functional effects of noncoding ultraconserved elements in human cancers. Sci Adv. 2025;11:eado2830. https:\/\/doi.org\/10.1126\/sciadv.ado2830.","journal-title":"Sci Adv"},{"key":"933_CR31","doi-asserted-by":"publisher","first-page":"6443","DOI":"10.1016\/j.csbj.2022.11.036","volume":"20","author":"M Machowska","year":"2022","unstructured":"Machowska M, Galka-Marciniak P, Kozlowski P. Consequences of genetic variants in miRNA genes. Comput Struct Biotechnol J. 2022;20:6443\u201357. https:\/\/doi.org\/10.1016\/j.csbj.2022.11.036.","journal-title":"Comput Struct Biotechnol J"},{"key":"933_CR32","doi-asserted-by":"publisher","unstructured":"Machowska M, Sz\u00f3stak N, Tire A, Wegorek W, Suszynska M, Kajdasz A, et al. miRNA gene mutations commonly disrupt the proper functioning of miRNA genes. Res Square. 2025. https:\/\/doi.org\/10.21203\/rs.3.rs-7029847\/v1.","DOI":"10.21203\/rs.3.rs-7029847\/v1"},{"key":"933_CR33","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","volume":"578","author":"LA Aaltonen","year":"2020","unstructured":"Aaltonen LA, Abascal F, Abeshouse A, Aburatani H, Adams DJ, Agrawal N, et al. Pan-cancer analysis of whole genomes. Nature. 2020;578:82\u201393. https:\/\/doi.org\/10.1038\/s41586-020-1969-6.","journal-title":"Nature"},{"key":"933_CR34","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41586-019-1689-y","volume":"575","author":"P Priestley","year":"2019","unstructured":"Priestley P, Baber J, Lolkema MP, Steeghs N, de Bruijn E, Shale C, et al. Pan-cancer whole-genome analyses of metastatic solid tumours. Nature. 2019;575:210\u20136. https:\/\/doi.org\/10.1038\/s41586-019-1689-y.","journal-title":"Nature"},{"key":"933_CR35","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov LB, Kim J, Haradhvala NJ, Huang MN, Tian Ng AW, Wu Y, et al. The repertoire of mutational signatures in human cancer. Nature. 2020;578:94\u2013101. https:\/\/doi.org\/10.1038\/s41586-020-1943-3.","journal-title":"Nature"},{"key":"933_CR36","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/s0092-8674(00)00078-7","volume":"102","author":"M Muramatsu","year":"2000","unstructured":"Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 2000;102:553\u201363. https:\/\/doi.org\/10.1016\/s0092-8674(00)00078-7.","journal-title":"Cell"},{"key":"933_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btad756","volume":"39","author":"M D\u00edaz-Gay","year":"2023","unstructured":"D\u00edaz-Gay M, Vangara R, Barnes M, Wang X, Islam SMA, Vermes I, et al. Assigning mutational signatures to individual samples and individual somatic mutations with SigProfilerAssignment. Bioinformatics. 2023;39:btad756. https:\/\/doi.org\/10.1093\/bioinformatics\/btad756.","journal-title":"Bioinformatics"},{"key":"933_CR38","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1200\/JCO.23.01053","volume":"42","author":"D Noerenberg","year":"2024","unstructured":"Noerenberg D, Briest F, Hennch C, Yoshida K, Hablesreiter R, Takeuchi Y, et al. Genetic characterization of primary mediastinal B-cell lymphoma: pathogenesis and patient outcomes. J Clin Oncol. 2024;42:452\u201366. https:\/\/doi.org\/10.1200\/JCO.23.01053.","journal-title":"J Clin Oncol"},{"key":"933_CR39","doi-asserted-by":"publisher","unstructured":"Cancer Genome Atlas Research Network, Ley TJ, Miller C, Ding L, Raphael BJ, Mungall AJ, et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368:2059\u201374. https:\/\/doi.org\/10.1056\/NEJMoa1301689.","DOI":"10.1056\/NEJMoa1301689"},{"key":"933_CR40","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41586-020-1965-x","volume":"578","author":"E Rheinbay","year":"2020","unstructured":"Rheinbay E, Nielsen MM, Abascal F, Wala JA, Shapira O, Tiao G, et al. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature. 2020;578:102\u201311. https:\/\/doi.org\/10.1038\/s41586-020-1965-x.","journal-title":"Nature"},{"key":"933_CR41","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1056\/NEJMoa1106968","volume":"366","author":"MJ Walter","year":"2012","unstructured":"Walter MJ, Shen D, Ding L, Shao J, Koboldt DC, Chen K, et al. Clonal architecture of secondary acute myeloid leukemia. N Engl J Med. 2012;366:1090\u20138. https:\/\/doi.org\/10.1056\/NEJMoa1106968.","journal-title":"N Engl J Med"},{"key":"933_CR42","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1182\/blood.2019001880","volume":"134","author":"RI Panea","year":"2019","unstructured":"Panea RI, Love CL, Shingleton JR, Reddy A, Bailey JA, Moormann AM, et al. The whole-genome landscape of Burkitt lymphoma subtypes. Blood. 2019;134:1598\u2013607. https:\/\/doi.org\/10.1182\/blood.2019001880.","journal-title":"Blood"},{"key":"933_CR43","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Weinstein JN, Collisson EA, Mills GB, Shaw KRM, Ozenberger BA, Ellrott K, et al. The cancer genome atlas pan-cancer analysis project. Nat Genet. 2013;45:1113\u201320. https:\/\/doi.org\/10.1038\/ng.2764.","journal-title":"Nat Genet"},{"key":"933_CR44","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"GTEx Consortium","year":"2020","unstructured":"GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369:1318\u201330. https:\/\/doi.org\/10.1126\/science.aaz1776.","journal-title":"Science"},{"key":"933_CR45","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1093\/nar\/gkg595","volume":"31","author":"M Zuker","year":"2003","unstructured":"Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 2003;31:3406\u201315.","journal-title":"Nucleic Acids Res"},{"key":"933_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.101023","volume":"3","author":"MO Urbanek-Trzeciak","year":"2022","unstructured":"Urbanek-Trzeciak MO, Kozlowski P, Galka-Marciniak P. miRMut: Annotation of mutations in miRNA genes from human whole-exome or whole-genome sequencing. STAR Protoc. 2022;3:101023. https:\/\/doi.org\/10.1016\/j.xpro.2021.101023.","journal-title":"STAR Protoc"}],"container-title":["Cellular & Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-026-00933-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-00933-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-00933-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:50:20Z","timestamp":1785801020000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11658-026-00933-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["933"],"URL":"https:\/\/doi.org\/10.1186\/s11658-026-00933-9","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read the manuscript and provided their consent for the submission.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"127"}}